3.80
Panoramica
Notizia
Cronologia dei prezzi
Catena di opzioni
Perché IBIO Giù?
Forum
Previsione
Frazionamento azionario
Precedente Chiudi:
$4.12
Aprire:
$3.91
Volume 24 ore:
369.59K
Relative Volume:
0.79
Capitalizzazione di mercato:
$37.52M
Reddito:
$2.05M
Utile/perdita netta:
$-23.15M
Rapporto P/E:
-0.573
EPS:
-6.6319
Flusso di cassa netto:
$-16.93M
1 W Prestazione:
-13.83%
1M Prestazione:
-40.72%
6M Prestazione:
+68.14%
1 anno Prestazione:
+29.25%
iBio Inc Stock (IBIO) Company Profile
Nome
iBio Inc
Settore
Industria
Telefono
302-355-0650
Indirizzo
600 Madison Avenue, Suite 1601, New York, NY
Confronta IBIO con altri titoli
Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
---|---|---|---|---|---|---|
![]()
IBIO
iBio Inc
|
3.80 | 37.52M | 2.05M | -23.15M | -16.93M | -6.6319 |
![]()
VRTX
Vertex Pharmaceuticals Inc
|
484.01 | 124.29B | 11.02B | -535.60M | -978.00M | -2.20 |
![]()
REGN
Regeneron Pharmaceuticals Inc
|
610.64 | 68.39B | 14.20B | 4.41B | 3.54B | 38.28 |
![]()
ARGX
Argen X Se Adr
|
590.06 | 35.99B | 2.19B | 833.04M | -1.28B | 12.71 |
![]()
ALNY
Alnylam Pharmaceuticals Inc
|
262.16 | 33.93B | 2.25B | -278.16M | -42.59M | -2.17 |
![]()
ONC
Beigene Ltd Adr
|
264.32 | 28.47B | 3.81B | -644.79M | -669.77M | -6.24 |
iBio Inc Stock (IBIO) Upgrades & Downgrades
Data | Azione | Analista | Modifica della valutazione |
---|---|---|---|
2024-05-28 | Iniziato | Chardan Capital Markets | Buy |
2021-11-29 | Iniziato | JMP Securities | Mkt Outperform |
2021-01-22 | Iniziato | Cantor Fitzgerald | Overweight |
2020-06-26 | Iniziato | Alliance Global Partners | Buy |
iBio Inc Borsa (IBIO) Ultime notizie
iBio, Inc. Common Stock (IBIO): Among Stocks Insiders Were Buying In Q1 2025 - Insider Monkey
20 Stocks Insiders Were Buying In Q1 2025 - Insider Monkey
FY2025 Earnings Forecast for iBio Issued By Chardan Capital - Defense World
iBio (NYSEMKT:IBIO) Trading Down 2.9% – Time to Sell? - Defense World
iBio (NYSE:IBIO) Upgraded by StockNews.com to “Sell” Rating - Defense World
Contrasting iBio (NYSE:IBIO) & Pharmaxis (OTCMKTS:PXSLY) - Defense World
iBio Inc. stock rises Monday, outperforms market - MarketWatch
iBio Inc. stock rises Friday, outperforms market - MarketWatch
iBio Inc. stock rises Thursday, outperforms market - MarketWatch
iBio stock soars to 52-week high, reaches $5.03 - Investing.com
iBio stock soars to 52-week high, reaches $5.03 By Investing.com - Investing.com South Africa
iBio Inc. stock falls Wednesday, underperforms market - MarketWatch
iBio Inc. stock rises Tuesday, outperforms market - MarketWatch
iBio Inc. stock falls Monday, still outperforms market - MarketWatch
iBio, Inc. Advances in Therapeutics and Leadership - TipRanks
iBio Inc. stock falls Friday, underperforms market - MarketWatch
iBio Inc. stock falls Thursday, underperforms market - MarketWatch
iBio to Begin Trading on the Nasdaq Stock Exchange - GlobeNewswire
iBio Inc. stock rises Wednesday, outperforms market - MarketWatch
iBio Announces Transfer to Nasdaq Capital Market - TipRanks
Can iBio's Nasdaq Move Transform Its Market Presence? Key Details Revealed - StockTitan
Is Ibio, Inc. (IBIO) Among Stocks Insiders Are Buying This Year? - Insider Monkey
10 Stocks Insiders Are Buying This Year - Insider Monkey
Ibio Inc Faces Financial Risk from Potential Stockholder Equity Dilution and Capital Raising Challenges - TipRanks
iBio Inc. stock falls Tuesday, underperforms market - MarketWatch
SEC Form 424B3 filed by iBio Inc. - Quantisnow
iBio Inc. stock falls Monday, underperforms market - MarketWatch
iBio Inc. (IBIO) reports earnings - Quartz
iBio, Inc. Reports Second Quarter Fiscal 2025 Financial Results and Corporate Updates on Advancements in Cardiometabolic Therapeutics - Nasdaq
iBio Reports Fiscal Second Quarter 2025 Financial Results - GlobeNewswire
IBIO's Strategic Pivot: AI-Powered Antibody Discovery Shows Promise Despite Q2 Losses - StockTitan
A Tale of Resilience: iBio Inc Amid Stock Market Turbulence - The InvestChronicle
iBio (IBIO) Projected to Post Quarterly Earnings on Friday - Defense World
iBio (NYSE:IBIO) Trading Up 4% – Time to Buy? - Defense World
iBio (NYSEMKT:IBIO) Trading Up 1.3% – Still a Buy? - Defense World
iBio Inc Azioni (IBIO) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):